eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
NOWOŚĆ
Portal dla gastroenterologów!
www.egastroenterologia.pl
SCImago Journal & Country Rank
3/2024
vol. 19
 
Poleć ten artykuł:
Udostępnij:
Artykuł oryginalny

Microbial profile of biliary tract infection in patients undergoing therapeutic endoscopic retrograde cholangiopancreatography (ERCP), and baseline risk factors predicting microbial growth and post-ERCP cholangitis

Hina Ismail
1
,
Raja Taha Yaseen Khan
1
,
Syed Mudassir Laeeq
1
,
Zain Majid
1
,
Abbas Ali Tasneem
1
,
Farina M. Hanif
1
,
Nasir Hasan Luck

  1. Department of Hepato-gastroenterology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan
Data publikacji online: 2024/03/11
Plik artykułu:
- Microbial.pdf  [0.11 MB]
Pobierz cytowanie
 
Metryki PlumX:
 

Introduction

The diagnosis and treatment of many pancreaticobiliary disorders requires endoscopic retrograde cholangiopancreatography (ERCP). The sterility of the bile duct is established by the flushing action of bile and the bacteriostatic effects of bile salts [1]. Stasis or obstruction of bile flow can result in bacterial colonization of the biliary tree [2]. The most common organisms seen in biliary tract infection are Escherichia coli, Klebsiella, and Enterococcus species [3].
Studies have revealed that 0.5% to 3% of the cases undergoing ERCP developed cholangitis after ERCP [4, 5]. Factors predisposing to the development of post-ERCP cholangitis (PEC) include severe nature of obstruction, tight stricture needing long duration of ERCP, lack of sterile technique, incomplete drainage, and amount of dye injected into an obstructed system [6].
PEC not only increases the length of stay in hospital and hence financial burden on the patients, but also increases the morbidity and mortality. Complications of PEC include development of sepsis, cholangitic liver abscess, and acute renal injury. The reported mortality due to cholangitis is 4.5% [6].
Because the development of PEC carries important clinical implications, it is essential to identify factors that can predict its development, enabling better management of patients with fewer complications.

Aim

The aim of this study was to establish the bacterial profiles isolated from the bile sample and their role in selecting pre-emptive antibiotic therapy. In addition, we evaluated the pre-ERCP risk factors predicting the microbial growth and development of PEC.

Material and methods

Operational defnition
Acute cholangitis [7]: Acute cholangitis was diagnosed when at least 3 of the following were present within 24–36 h of ERCP.
Clinical parameters: New-onset right upper abdominal pain.
Laboratory parameters: Rise in temperature > 38°C/100.4°F, rise in blood cells < 4 or > 10 ×/µl, rise in total bilirubin > 2 mg/dl.
Methodology
Study design: prospective cohort study. Duration of study: January 2021 to December 2021 (1 year). Study setting and population: Department of Hepato-gastroenterology, Sindh Institute of Urology and Transplantation.
Inclusion criteria
Patients of either gender aged > 18 years undergoing index ERCP procedure for various biliary or pancreatic disorders.
Exclusion criteria
  1. Those having concurrent sepsis.
  2. Failed bile aspiration.
  3. Patients who had altered biliary anatomy due to previous hepatobiliary surgery, e.g. hepaticojejunostomy, Whipple’s procedure, etc.
  4. Patients who had previous history of ERCP.
Data collection procedure
All the patients fulfilling the inclusion criteria were enrolled in this study. After taking informed consent, the patients’ demographic and clinical information were obtained and were entered into a predesigned form including the patient’s gender and age, endoscopic diagnoses, preoperative jaundice, drug therapy, common bile duct diameter, and papilla types.
The ERCP interventions were performed using a therapeutic duodenoscope (TJF-260V; Olympus Optical, Tokyo, Japan). All duodenoscopes were disinfected and decontaminated according to the guidelines. The selective cannulation was performed via the common bile duct by using a guidewire in all the patients. Once the guidewire cannulation was established, bile was aspirated by inserting a single-use, 5F, standard sphincterotome catheter into the bile duct before the injection of a contrast agent for the ERCP procedure. Approximately 2–8 ml of bile (average 4 ml) was collected in a 10 ml sterile syringe.
Statistical analysis
Data entry and analysis was done using Statistical Program for Social Sciences (SPSS) version 20 (IBM Corporation, Armonk, NY, USA). Continuous variables were expressed as mean and standard deviation, while categorical variables like gender, indication of procedure, presence of Gram-positive and Gram-negative organisms and multi-drug-resistant (MDR) organisms in bile culture along with duration of treatment were presented as frequencies and percentages. There were 2 outcome variables. One was the presence or absence of organisms in bile culture and the second one was the development of PEC. A p-value < 0.05 was considered significant.
Results
The total number of patients was 280. Baseline characteristics are shown in Table I. Out of them, 145 (51.8%) patients were males. Mean age was 47.14 ±12.8 years and 154 (55.4%) patients were more than 45 years old. The most common presenting complaint was abdominal pain, which was noticed in 212 (75.7%) patients, followed by jaundice in 204 (72.9%) patients and weight loss in 143 (51.2%) patients. The most common indication for ERCP was common bile duct (CBD) stricture, seen in 164 (58%) patients, followed by CBD stone in 60 (21%) patients and chronic pancreatitis in 26 (9%) patients (Figure 1). Bile Culture was positive in 195 (69.6%) patients and post-ERCP cholangitis developed in 187 (66.8%) patients. The most common organism in bile culture was Escherichia coli (E. coli) seen in 82 (42%) followed by Pseudomonas aeruginosa in 50 (25.6%) patients, multiple organisms in 25 (12.8%), Klebsiella in 24 (12.3%), Acinetobacter in 12 (6.1%), and Enterococcus in 2 (1%) patients (Table II).
Out of 195 positive bile cultures, MDR organisms were noted in 119 (61%) patients. The most common cause of MDR infection was E. coli, seen in 43 (36.1%) patients, followed by Pseudomonas aeruginosa in 25 (21%), Klebsiella in 20 (16.8%), multiple organisms in 20 (16.8%), and Acinetobacter in 11 (9%) patients (Figure 2). Most commonly, organisms were sensitive to carbapenems followed by piperacillin/tazobactam, tigecycline, cefepime, ceftriaxone, ampicillin, amoxicillin, and ciprofloxacin, respectively.
Among the 195 patients with positive bile culture, 179 developed post-ERCP cholangitis. On multivariate analysis, preoperative jaundice, history of abdominal pain, and weight loss on admission along with ERCP performed for CBD stricture and CBD stone were independent predictors of positive bile culture on ERCP (Tables III and IV), while age greater than 45 years, presence of preoperative jaundice, abdominal pain and weight loss, positive bile culture along with ERCP performed for CBD stricture were independent risk factors for the development of post-ERCP cholangitis (Tables V and VI).

Discussion

The sterility and continuous bile flow in the biliary system is an unfavourable medium for bacterial or organism growth. Blockage of bile duct due to any aetiology can result in bile stasis, allowing the bacteria and other organisms that are transferred through duodenal papillae to reside, replicate, and colonize in the bile duct, resulting in severe consequences including cholangitis and biliary tract infection.8
Herein, we identified the microbial profile in the patients undergoing index ERCP. The bile culture positivity rate was 74.6%, i.e. 209 out of 279 patients had positive bile culture. Gram-negative bacteria was the leading cause of bacterial growth, accounting for 86% of the positive cultures. Among Gram-negative bacteria, E.coli was the leading cause, followed by Pseudomonas aeruginosa, multiple organsims, Acinobacter, Klebseilla, and Enterococci species. Our microbial profile was comparable to that seen in other studies, and similar to intestinal flora [8–11]. A study done by Hadi et al. [12] reported 36% positivity of bile culture in patients undergoing cholecystectomy with Gram-negative bacteria, accounting for 80% of the positive cultures, with a microbial profile similar to that of our population. Similarly, Ruan et al. reported a bile culture positivity rate of 38% in patients undergoing ERCP in a Chinese population [11]. In comparison to other studies, the high positivity of bile culture in our population was due to prolonged stasis of bile prior to ERCP, because the most common indication for ERCP in our patients was CBD stricture followed by CBD stone. There are other studies reporting variable bile culture positivity rates in different populations, ranging from 16% to 85% [9, 13–18].
In our study, bile was colonized by a single organism in most of the cases, as compared to the multiple organisms. This finding was comparable with the other studies – Ruan et al. and Kaya et al. revealed similar results [9, 11]. In contrast, a few other studies reported higher rates of multimicrobial growth in bile culture [14, 19]. This difference might be due to prolonged and overuse of antibiotics prophylactically prior to the ERCP in some areas or due to substandard culture medium. E. coli was the most common strain colonizing the biliary tract, followed by Pseudomonas, Acinetobacter, Klebseilla, and Enterococci. E. coli is a common organism colonizing the gastrointestinal tract, while Klebseilla and Acinetobacter colonize both the gastrointestinal and respiratory tracts causing opportunistic infections [20, 21]. MDR infections were more common in our population due to easy availability of the broad spectrum antibiotics, which are prophylactically prescribed by local general practitioners. The recommended prophylactic treatment option for the prevention of PEC in patients undergoing ERCP includes cephalosporin or -lactamase antibiotics [22]. Considering the prevalence of MDR infections in our population, most organisms were sensitive to carbapenems, followed by -lactamase antibiotics and cephalosporins. The knowledge of this microbial profile and their antibiotic sensitivities will aid us in the usage of appropriate antibiotics for these organisms prophylactically and can also help in avoidance of antibiotic resistance.
On multivariate analysis, presence of jaundice, abdominal pain, and weight loss on admission together with ERCP performed for CBD stone and stricture were independent factors predictive of positive bile culture. This higher tendency of positive bile culture in patients with prolonged CBD stricture can be explained by the fact that biliary malignancies result in cachexia and malnutrition, leading to weight loss and decreased immunity and impaired mucosal response to pathogens resulting in bile colonization of opportunistic organisms and infection. Prolonged stasis and longer disease duration, as seen in patients with either benign or malignant CBD stricture or CBD stone, also result in biliary obstruction and proximal biliary tree dilatation causing bile stasis resulting in microbial retention and growth.
In our study, we also found that patients presenting with either jaundice, abdominal pain, weight loss with or without advanced age, undergoing ERCP for CBD stricture and positive bile culture at ERCP were at high risk of developing PEC. This can again be explained by the fact that all these findings are seen in prolonged stasis due to malignant strictures resulting in cachexia, malnutrition, and impaired immunity leading to impaired mucosal barrier causing microbial colonization and PEC. A study by Mahafzah and Daradkeh showed positive correlation between bile culture positivity and advanced age [23]. In our study, similar results were noted as the patients having age greater than 45 years were at increased risk of PEC. The knowledge of these factors causing PEC can help the clinician to start the broad-spectrum antibiotics prior to ERCP after a discussion with a multidisciplinary team involving, in particular, the infectious disease team.
Currently, prophylactic antibiotic treatment prior to ERCP is not routinely recommended. However, it is required when there is a need of repeated biliary interventions to achieve adequate biliary decompressions [22, 24].
There were certain limitations to our study. Firstly, it was a single-centred study, and secondly, the sample size was small. Hence, there is a need for a multicentric study with larger sample size to recommend prophylactic antibiotics to patients who are at high risk of developing PEC.
However, the strength of our study was that it was cross-sectional and pioneering study from this part of the world that revealed the microbial profile of biliary tract and risk factors predictive of PEC cholangitis. We followed strict protocols to perform all ERCP procedures by sterilizing all the instruments according to the international standards prior to the procedure to avoid cross-transmission between the patients.

Conclusions

The microbial profile and risk factors for positive bile culture and PEC were evaluated. Advanced age, pre-operative jaundice, abdominal pain, and weight loss along with prolonged biliary stasis were independent risk factors for these conditions. Therefore, there should be a proper preoperative management plan including a multidisciplinary approach for the commencement of prophylactic antibiotic therapy in these high-risk patients prior to ERCP.

Conflict of interest

The authors declare no conflict of interest.
References
1. Sung JY, Costerton JW, Shaffer EA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci 1992; 37: 689-96.
2. Hochwald SN, Burke EC, Jarnagin WR, et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999; 134: 261-6.
3. Chen M, Wang L, Wang Y, et al. Risk factor analysis of post ERCP cholangitis: a single-center experience. Hepatobiliary Pancreat Dis Int 2018; 17: 55-8.
4. Kapral C, Mühlberger A, Wewalka F, et al. Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation. Eur J Gastroenterol Hepatol 2012; 24: 1447-54.
5. Li ZS, Xu GM, Sun ZX, et al. Early complications of diagnostic and therapeutic ERCP and its treatment. Chin J Dig Endosc 2002; 19: 77-80.
6. Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci 2018; 25: 17-30.
7. Boey JH, Way LW. Acute cholangitis. Ann Surg 1980; 191: 264-70.
8. Ortiz-Brizuela E, Sifuentes-Osornio J, Manzur-Sandoval D, et al. Acute cholangitis after bilioenteric anastomosis for bile duct injuries. J Gastrointest Surg 2017; 21: 1613-9.
9. Kaya M, Beştaş R, Bacalan F, et al. Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. World J Gastroenterol 2012; 18: 3585-9.
10. Voigtländer T, Leuchs E, Vonberg RP, et al. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis. J Infect 2015; 70: 483-90.
11. Ruan HQ, Liao GL, Peng P, et al. Microbial profiles and risk factors of preexisting biliary infection in patients with therapeutic endoscopy. Gastroenterol Res Pract 2019; 2019: 1527328.
12. Hadi YB, Waqas M, Umer HM, et al. Bacterobilia in acute cholecystitis: bile cultures’ isolates, antibiotic sensitivities and antibiotic usage. A study on a Pakistani population. J Pakistan Med Assoc 2016; 66 Suppl. 3: S50-2.
13. Rerknimitr R, Fogel EL, Kalayci C, et al. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 2002; 56: 885-9.
14. Negm AA, Schott A, Vonberg RP, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010; 72: 284-91.
15. Sakata J, Shirai Y, Tsuchiya Y, et al. Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbeck’s Arch Surg 2009; 394: 1065-72.
16. Pohl J, Ring A, Stremmel W, Stiehl A. The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2006; 18: 69-74.
17. Millonig G, Buratti T, Graziadei IW, et al. Bactobilia after liver transplantation: frequency and antibiotic susceptibility. Liver Transpl 2006; 12: 747-53.
18. Kiesslich R, Holfelder M, Will D, et al. Interventional ERCP in patients with cholestasis. Degree of biliary bacterial colonization and antibiotic resistance. Z Gastroenterol 2001; 39: 985-92.
19. Alves JR, Silva RC, Guerra SCP, et al. Microbiological analysis of bile in patients with benign and malignant biliopancreatic diseases and its consequences. Arq Gastroenterol 2016; 53: 156-62.
20. Yu H, Guo Z, Xing W, et al. Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Interv Radiol 2012; 35: 1136-44.
21. Cuervo SI, Sánchez R, Gómez-Rincón JC, et al. Comportamiento de casos de Klebsiella pneumoniae productora de carbapenemasas en pacientes con cáncer de un hospital de tercer nivel de Bogotá, D.C. Biomédica 2014; 34 Suppl. 1: 170-80.
22. Sun Z, Zhu Y, Zhu B, et al. Controversy and progress for treatment of acute cholangitis after Tokyo Guidelines (TG13). BioScience Trends 2016; 10: 22-6.
23. Mahafzah AM, Daradkeh SS. Profile and predictors of bile infection in patients undergoing laparoscopic cholecystectomy. Saudi Med J 2009; 30: 1044-8.
24. Ishaq S, Lipp A. Antibiotic prophylaxis in gastrointestinal endoscopy. Gut 2010; 59: 1300.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
© 2024 Termedia Sp. z o.o.
Developed by Bentus.